Results 51 to 60 of about 4,973 (169)

Electroacupuncture Alleviates Comorbid Depression‐Like Behaviors and Dyspepsia‐Like Symptoms in Rats Accompanied by Alterations in Hippocampal Neuroinflammation and Gut Microbiota

Brain and Behavior, Volume 16, Issue 10, October 2026.
EA improves depression and dyspepsia via brain‐gut axis regulation ABSTRACT Background Depression and dyspepsia are highly comorbid in clinical practice, and their occurrence and progression are closely associated with dysfunction of the brain–gut axis.
Tianlang Wang, Yifan Feng, Xihan Wang, Yanan Xue, Jianbo Wang, Yi Qu, Tieming Ma, Jidong Liu   +7 more
wiley   +1 more source

Recurrent Congenital Hiatal Hernia After Laparoscopic Repair Complicated by Gastric Perforation and Abdominal Compartment Syndrome

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Complete excision of the hernial sac during congenital hiatal hernia repair may help prevent recurrence. This case also emphasizes the importance of early recognition and prompt management of abdominal compartment syndrome when progressive abdominal distension and organ dysfunction develop postoperatively.
Takayuki Fujii, Yui Noguchi, Nanami Harada, Hiroto Katami, Aya Tanaka   +4 more
wiley   +1 more source

Current Pharmacological Management of Gastroesophageal Reflux Disease

Gastroenterology Research and Practice, 2013
Gastroesophageal reflux disease (GERD), a common disorder with troublesome symptoms caused by reflux of gastric contents into the esophagus, has adverse impact on quality of life.
Yao-Kuang Wang, Wen-Hung Hsu, Sophie S. W. Wang, Chien-Yu Lu, Fu-Chen Kuo, Yu-Chung Su, Sheau-Fang Yang, Chiao-Yun Chen, Deng-Chyang Wu, Chao-Hung Kuo   +9 more
doaj   +1 more source

Evaluation of the Additive Effect of Domperidone on Patients with Refractory Gastroesophageal Reflux Disease Symptoms; A Randomized Double Blind Clinical Trial

Middle East Journal of Digestive Diseases, 2019
BACKGROUND Gastroesophageal reflux disease (GERD) is a common problem with annoying symptoms. It is associated with negative impact on quality of life.
Tarang Taghvaei, Arash Kazemi, Vahid Hosseini, Mehdi Hamidian, Hafez Tirgar Fakheri, Seyyed Abbas Hashemi, Iradj Maleki   +6 more
doaj   +1 more source

A Multicenter, Prospective Real‐World Study of Simethicone–Activated Charcoal in Patients With Persistent Dyspeptic Symptoms Despite Acid Suppression (SIMAC Study)

JGH Open, Volume 10, Issue 10, October 2026.
ABSTRACT Background Persistent gas‐predominant dyspeptic symptoms affect many patients despite adequate proton pump inhibitor (PPI) therapy, reflecting mechanisms beyond acid secretion. We evaluated the real‐world effectiveness and safety of simethicone (80 mg) plus activated charcoal (250 mg) in adults with persistent symptoms despite prior PPI ...
Ashish Kumar, D. V. Sreenivas, Sambit Kumar Behera, Guduru Raghavendra Srinivas Rao, G. S. Sameer Kumar, Jaya Ghosh Chatterjee, Nalini Kant Choudhary, Ravi Shankar Bagepally, Shekhar Puri, S. M. A. Rizvi, Rahul Pathak, Shruti Pal   +11 more
wiley   +1 more source

Iron and Other Metal Ions in Human Health and Disease

MedComm, Volume 7, Issue 10, October 2026.
Iron, copper, zinc, and calcium orchestrate cellular function through distinct yet cooperative mechanisms: redox‐active iron and copper cycle between oxidation states to act as Fenton catalysts and electron carriers in oxidative phosphorylation (OXPHOS); redox‐inert zinc serves as a structural component of zinc‐finger proteins and a catalytic cofactor ...
Xiaofeng Dai, Jitian Li
wiley   +1 more source

Effect of GLP‐1 receptor agonist on nutrient intake: A narrative review

Nutrition in Clinical Practice, Volume 41, Issue 5, Page 1308-1317, October 2026.
Abstract Humans have a primitive defense mechanism called metabolic adaptation that slows voluntary weight loss. It works by downregulating hormones that reduce food intake and by lowering the metabolic rate. Second‐generation GLP‐1 receptor agonists, such as semaglutide or tirzepatide, promote weight loss by targeting this hormonal system to control ...
Ken Fujioka
wiley   +1 more source

Comparative analysis of the treatment outcomes of Itopride and Acotiamide in functional dyspepsia: a real-world retrospective study

Клинический разбор в общей медицине
Background. Functional dyspepsia (FD) is a prevalent gastric neuromuscular disorder affecting approximately 20% of the global population, with significant economic implications, particularly in India, where prevalence rates vary between 7.6% and 49 ...
Sanjay Kumar Bandyopadhyay, B. Ravi Shankar, Omesh Goyal   +2 more
doaj   +1 more source

GLP‐1‐Based Therapies in Type 1 Diabetes: Emerging Evidence on Cardiovascular, Renal, and Safety Outcomes

Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 8757-8768, October 2026.
ABSTRACT Background Individuals living with type 1 diabetes (T1D) are at increased risk for cardiovascular (CV) and renal complications, yet therapeutic strategies specifically targeting cardiorenal risk reduction in this population remain limited. The role of glucagon‐like peptide‐1 (GLP‐1)‐based therapies in T1D remains unclear.
Anastasios Tentolouris, Djordje S. Popovic, Alexandros L. Liarakos, Alexandros Briasoulis, Nikolaos Papanas, Theocharis Koufakis   +5 more
wiley   +1 more source

State-of-the-Art Treatment of Irritable Bowel Syndrome – Recent Advances and Emerging Therapeutic Alternatives [PDF]

European Medical Journal Gastroenterology, 2013
Irritable bowel syndrome (IBS) is a highly prevalent functional disorder characterised by chronic and recurrent abdominal pain and altered bowel habit. Numerous pharmacological and non pharmacological treatment options have proven to have some benefit in
Magnus Simrén
doaj